Skip to main content Scroll Top
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Most Viewed Posts
Clear Filters
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
1 April 2026
REGEnLIFE cures inflammatory brain diseases with light
REGEnLIFE cures inflammatory brain diseases with light
21 February 2025
Photobiomodulation: light to treat Alzheimer’s disease
Photobiomodulation: light to treat Alzheimer’s disease
2 July 2024
1 November 2022

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Read the article
JAD Journal of Alzheimer's Disease

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

PMID: 36189591 Clinical Trial.

Share this article